GlassScriptPhysician profile
Hussein Hussein
NPI 1205144045
$843.92
in general payments reported to CMS, 2019-2025
9 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.24 · 2022: $134 · 2024: $544 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $479 · Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $478.53 |
| Food and Beverage | $215.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $478.53 | 2024 | Single Use Suction Valve (Sterile) |
| Pulmonx Corporation | $134.09 | 2022 | |
| United Therapeutics Corporation | $108.88 | 2025 | |
| Genzyme Corporation | $31.83 | 2024 | |
| Glaxosmithkline, LLC. | $21.13 | 2025 | Nucala |
| Haemonetics Corporation | $19.40 | 2025 | Teg6s Hemostasis System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.64 | 2024 | Tradjenta, Synjardy, Jardiance |
| Insmed, INC. | $16.24 | 2020 | |
| Stryker Corporation | $15.18 | 2024 | Css Cannulated Screw System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hussein Hussein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.